Pipeline
Overview
NeuraLight is a part of multiple clinical partnerships for different CNS diseases conducted in leading medical centers worldwide. More information can be found here.
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Healthy Subjects | |||
| Parkinson’s Disease (PD) | |||
| Amyotrophic Lateral Sclerosis (ALS) | |||
| Multiple Sclerosis (MS) | |||
| Progressive Supranuclear Palsy (PSP) | |||
| Multiple System Atrophy (MSA) | |||
Partnerships
Partner with us to accelerate your CNS drug development
